New et al. reported that target capture sequencing of a 6 Mb region flanking CYP21A2, facilitated noninvasive genotype analysis of fetus in CAH using relative haplotype dosage (RHDO) analysis18. This evidence concerns the gene CYP21A2 and congenital adrenal hyperplasia.